HZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and Adolescents
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare the efficacy and safety of fluticasone
furoate/vilanterol (GW642444) inhalation powder administered once daily with fluticasone
propionate/salmeterol administered twice daily in adolescent and adult subjects 12 years of
age and older with persistent bronchial asthma over a 24-week period.
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Fluticasone Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Salmeterol Xinafoate Xhance